Literature DB >> 19270471

The effects of dysthymic disorder on health-related quality of life and disability days in persons with comorbid medical conditions in the general population.

Bernhard T Baune1, Riccardo N Caniato, Volker Arolt, Klaus Berger.   

Abstract

BACKGROUND: We aimed to investigate in medical disorders the effects of comorbid dysthymic disorder as compared to major depressive disorder (MDD) on health-related quality of life (HR-QoL) and disability days in the general population.
METHODS: In a population-based study 4,181 individuals were assessed for the presence of dysthymic disorder and depression, utilizing the Composite International Diagnostic Interview. Each participant received a thorough medical examination to assess the presence of comorbid somatic conditions. HR-QoL was evaluated using the Medical Outcomes Survey Short-Form 36 (SF-36) and disability days were provided by self-report. Descriptive statistics, analysis of variance and multivariable logistic regression were used.
RESULTS: Comorbidity with illnesses from a maximum of 6 somatic disease groups was more prevalent in persons with dysthymic disorder (78.7%) than in those with MDD (70.4%). Persons with dysthymic disorder had a significantly lower mental health summary score in the SF-36 and more disability days than those with MDD. The physical health summary scores were not significantly different between participants with dysthymic disorder and MDD (after Bonferroni correction), suggesting that limitations in physical functioning due to comorbid medical conditions were similar in both affective disorder groups.
CONCLUSIONS: These results show that affective disorders comorbid with medical, somatic illnesses have a major impact on HR-QoL and disability with more pronounced effects in dysthymic disorder than in MDD. Differences in the time course of both conditions might contribute to this finding. Our results support the need for an improved identification and treatment of affective disorders in patients with somatic illnesses. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19270471     DOI: 10.1159/000206870

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  6 in total

1.  Incident Chronic Spinal Pain and Depressive Disorders: Data From the National Comorbidity Survey.

Authors:  Karen B Schmaling; Zachary A Nounou
Journal:  J Pain       Date:  2018-11-22       Impact factor: 5.820

2.  Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.

Authors:  Carlton Dampier; Petra LeBeau; Seungshin Rhee; Susan Lieff; Karen Kesler; Samir Ballas; Zora Rogers; Winfred Wang
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

3.  Hostility may explain the association between depressive mood and mortality: evidence from the French GAZEL cohort study.

Authors:  Cédric Lemogne; Hermann Nabi; Marie Zins; Sylvaine Cordier; Pierre Ducimetière; Marcel Goldberg; Silla M Consoli
Journal:  Psychother Psychosom       Date:  2010-02-20       Impact factor: 17.659

4.  Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity.

Authors:  Waguih William IsHak; Alexander J Steiner; Anna Klimowicz; Kaitlyn Kauzor; Jonathan Dang; Brigitte Vanle; Christina Elzahaby; Mark Reid; Lekeisha Sumner; Itai Danovitch
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 5.  Psychological distress is associated with vision-related but not with generic quality of life in patients with visual field defects after cerebral lesions.

Authors:  Carolin Gall; Iris Mueller; Gabriele H Franke; Bernhard A Sabel
Journal:  Ment Illn       Date:  2012-09-06

6.  Relationship of quality of life with disability grade in obsessive compulsive disorder and dysthymic disorder.

Authors:  Nv Roopesh Gopal; Cy Sudarshan; S Ganesh Kumar
Journal:  Indian J Palliat Care       Date:  2014-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.